FOX NEWS - Maryland-based Novavax will receive $1.6 billion through the government's Operation Warp Speed to develop a coronavirus vaccine as early as this year, the publicly traded company announced on Tuesday.RELATED: Montgomery County biotech company working on COVID-19 vaccine"The pandemic has caused an unprecedented public health crisis, making it more important than ever that industry, government and funding entities join forces to defeat the novel coronavirus together," Novavax President and CEO Stanley C.
Erck said in a statement. "We are honored to partner with Operation Warp Speed to move our vaccine candidate forward with extraordinary urgency in the quest to provide vital protection to our nation’s population."The government.